Skip to main content
Top
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Reasons for compliance or noncompliance with advice to test for hepatitis C via an internet-mediated blood screening service: a qualitative study

Authors: Freke R Zuure, Titia Heijman, Anouk T Urbanus, Maria Prins, Gerjo Kok, Udi Davidovich

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

Hepatitis C virus (HCV) is mainly transmitted by exposure to infected blood, and can lead to liver cirrhosis and liver cancer. Since the onset of HCV and the development of liver cirrhosis usually are asymptomatic, many HCV-infected individuals are still undiagnosed. To identify individuals infected with HCV in the general population, a low threshold, internet-mediated blood testing service was set up. We performed a qualitative study examining reasons for compliance and noncompliance with advice to test for HCV via the online blood testing service.

Methods

Semistructured telephone interviews were conducted with 33 website visitors who had been advised to test for HCV (18 testers, 15 non-testers). Transcribed interviews were analyzed qualitatively and interpreted using psychosocial theories of health behavior.

Results

Reasons for testing pertaining to the online service were: the testing procedure is autonomous, personalized test advice is provided online, reminder emails are sent, and there is an online planning tool. Reasons for testing not specific to the online service were: knowing one's status can prevent liver disease and further transmission of HCV, HCV is curable, testing can provide reassurance, physical complaints are present, and there is liver disease in one's social environment. Service-related reasons for not testing pertained to inconvenient testing facilities, a lack of commitment due to the low threshold character of the service, computer/printing problems, and incorrectly interpreting an online planning tool. The reasons for not testing that are not specific to the online service were: the belief that personal risk is low, the absence of symptoms, low perceived urgency for testing and treatment, fear of the consequences of a positive test result, avoiding threatening information, and a discouraging social environment.

Conclusions

Features specific to the online service played a significant role in motivation to test for HCV above and beyond the more conventional perceived health benefits of HCV testing. However, some online specific features were considered problematic and need to be adapted. Methods and strategies for dealing with these impeding factors and for improving compliance with testing via the online service are outlined.
Appendix
Available only for authorised users
Literature
1.
go back to reference Perz JF, Farrington LA, Pecoraro C, Hutin YJ, Armstrong GL: Estimated Global Prevalence of Hepatitis C Virus Infection. 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, MA, USA. Sept 30-Oct 3. 2004 Perz JF, Farrington LA, Pecoraro C, Hutin YJ, Armstrong GL: Estimated Global Prevalence of Hepatitis C Virus Infection. 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, MA, USA. Sept 30-Oct 3. 2004
2.
go back to reference McHutchison JG: Understanding hepatitis C. Am J Manag Care. 2004, 10: S21-S29.PubMed McHutchison JG: Understanding hepatitis C. Am J Manag Care. 2004, 10: S21-S29.PubMed
3.
go back to reference Micallef JM, Kaldor JM, Dore GJ: Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006, 13: 34-41. 10.1111/j.1365-2893.2005.00651.x.CrossRefPubMed Micallef JM, Kaldor JM, Dore GJ: Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006, 13: 34-41. 10.1111/j.1365-2893.2005.00651.x.CrossRefPubMed
4.
go back to reference Seeff LB: Natural history of chronic hepatitis C. Hepatology. 2002, 36 (Suppl-46): Seeff LB: Natural history of chronic hepatitis C. Hepatology. 2002, 36 (Suppl-46):
5.
go back to reference Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB: Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat. 2007, 14: 107-115. 10.1111/j.1365-2893.2006.00785.x.CrossRefPubMed Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB: Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat. 2007, 14: 107-115. 10.1111/j.1365-2893.2006.00785.x.CrossRefPubMed
6.
go back to reference Sypsa V, Touloumi G, Papatheodoridis GV, Tassopoulos NC, Ketikoglou I, Vafiadis I, Hatzis G, Tsantoulas D, Akriviadis E, Koutsounas S, Hatzakis A: Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. J Viral Hepat. 2005, 12: 543-550. 10.1111/j.1365-2893.2005.00588.x.CrossRefPubMed Sypsa V, Touloumi G, Papatheodoridis GV, Tassopoulos NC, Ketikoglou I, Vafiadis I, Hatzis G, Tsantoulas D, Akriviadis E, Koutsounas S, Hatzakis A: Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. J Viral Hepat. 2005, 12: 543-550. 10.1111/j.1365-2893.2005.00588.x.CrossRefPubMed
7.
go back to reference Grishchenko M, Grieve RD, Sweeting MJ, De AD, Thomson BJ, Ryder SD, Irving WL: Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice. Int J Technol Assess Health Care. 2009, 25: 171-180. 10.1017/S0266462309090229.CrossRefPubMed Grishchenko M, Grieve RD, Sweeting MJ, De AD, Thomson BJ, Ryder SD, Irving WL: Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice. Int J Technol Assess Health Care. 2009, 25: 171-180. 10.1017/S0266462309090229.CrossRefPubMed
8.
go back to reference National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C. Hepatology. 2002, 36: S3-20. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C. Hepatology. 2002, 36: S3-20.
9.
go back to reference Siebert U, Sroczynski G, Rossol S, Wasem J, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB: Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C. Gut. 2003, 52: 425-432. 10.1136/gut.52.3.425.CrossRefPubMedPubMedCentral Siebert U, Sroczynski G, Rossol S, Wasem J, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB: Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C. Gut. 2003, 52: 425-432. 10.1136/gut.52.3.425.CrossRefPubMedPubMedCentral
10.
go back to reference Vrolijk JM, DE Knegt RJ, Veldt BJ, Orlent H, Schalm SW: The treatment of hepatitis C: history, presence and future. Neth J Med. 2004, 62: 76-82.PubMed Vrolijk JM, DE Knegt RJ, Veldt BJ, Orlent H, Schalm SW: The treatment of hepatitis C: history, presence and future. Neth J Med. 2004, 62: 76-82.PubMed
11.
go back to reference Wong JB: Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies. Pharmacoeconomics. 2006, 24: 661-672. 10.2165/00019053-200624070-00005.CrossRefPubMed Wong JB: Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies. Pharmacoeconomics. 2006, 24: 661-672. 10.2165/00019053-200624070-00005.CrossRefPubMed
12.
go back to reference McHutchison JG, Bacon BR: Chronic hepatitis C: an age wave of disease burden. Am J Manag Care. 2005, 11: S286-S295.PubMed McHutchison JG, Bacon BR: Chronic hepatitis C: an age wave of disease burden. Am J Manag Care. 2005, 11: S286-S295.PubMed
13.
go back to reference Takkenberg B, de BJ, Weegink C, Jansen P, Reesink H: Novel therapies in hepatitis B and C. Curr Gastroenterol Rep. 2008, 10: 81-90. 10.1007/s11894-008-0013-z.CrossRefPubMed Takkenberg B, de BJ, Weegink C, Jansen P, Reesink H: Novel therapies in hepatitis B and C. Curr Gastroenterol Rep. 2008, 10: 81-90. 10.1007/s11894-008-0013-z.CrossRefPubMed
14.
go back to reference Health Council of the Netherlands: Committee on Hepatitis C: Detection and treatment of people with hepatitis C. 1997, Rijswijk Health Council of the Netherlands: Committee on Hepatitis C: Detection and treatment of people with hepatitis C. 1997, Rijswijk
15.
go back to reference Zuure FR, Davidovich U, Coutinho RA, Kok G, Hoebe CJ, van den Hoek A, Jansen PL, Van Leeuwen-Gilbert P, Verheuvel NC, Weegink CJ, Prins M: Using mass media and the internet as tools to diagnose hepatitis C infections in the general population. Am J Prev Med. 2011, 40: 345-352. 10.1016/j.amepre.2010.11.019.CrossRefPubMed Zuure FR, Davidovich U, Coutinho RA, Kok G, Hoebe CJ, van den Hoek A, Jansen PL, Van Leeuwen-Gilbert P, Verheuvel NC, Weegink CJ, Prins M: Using mass media and the internet as tools to diagnose hepatitis C infections in the general population. Am J Prev Med. 2011, 40: 345-352. 10.1016/j.amepre.2010.11.019.CrossRefPubMed
16.
go back to reference Gollwitzer PM: Implementation Intentions: Strong effects of simple plans. American Psychologist. 1999, 54: 493-501.CrossRef Gollwitzer PM: Implementation Intentions: Strong effects of simple plans. American Psychologist. 1999, 54: 493-501.CrossRef
17.
18.
go back to reference Rosenstock I: The health belief model and preventive health behavior. Health Education Monographs. 1974, 2: 354-386.CrossRef Rosenstock I: The health belief model and preventive health behavior. Health Education Monographs. 1974, 2: 354-386.CrossRef
19.
go back to reference Ajzen I: The theory of planned behavior. Organizational behavior and human decision processes. 1991, 50: 179-211. 10.1016/0749-5978(91)90020-T.CrossRef Ajzen I: The theory of planned behavior. Organizational behavior and human decision processes. 1991, 50: 179-211. 10.1016/0749-5978(91)90020-T.CrossRef
20.
go back to reference Witte K: Putting the fear back into fear appeals: The extended parallel process model. Communicaton Monographs. 1992, 59: 329-349. 10.1080/03637759209376276.CrossRef Witte K: Putting the fear back into fear appeals: The extended parallel process model. Communicaton Monographs. 1992, 59: 329-349. 10.1080/03637759209376276.CrossRef
21.
go back to reference Mikolajczak J, Hospers HJ, Kok G: Reasons for not taking an HIV-test among untested men who have sex with men: an Internet study. AIDS and Behavior. 2006, 10: 431-435. 10.1007/s10461-006-9068-8.CrossRefPubMed Mikolajczak J, Hospers HJ, Kok G: Reasons for not taking an HIV-test among untested men who have sex with men: an Internet study. AIDS and Behavior. 2006, 10: 431-435. 10.1007/s10461-006-9068-8.CrossRefPubMed
22.
go back to reference Glaser BG, Strauss A: The discovery of grounded theory: Strategies for qualitative research. 1967, Chicago, IL: Aldine Glaser BG, Strauss A: The discovery of grounded theory: Strategies for qualitative research. 1967, Chicago, IL: Aldine
23.
go back to reference Smith JA: Semi-structured interviewing and qualitative analysis. Rethinking Methods in Psychology. Edited by: Smith JA, Harre R, Langenhove LV. 1995, London: Sage, 9-26. Smith JA: Semi-structured interviewing and qualitative analysis. Rethinking Methods in Psychology. Edited by: Smith JA, Harre R, Langenhove LV. 1995, London: Sage, 9-26.
24.
go back to reference Skinner CS, Strecher VJ, Hospers H: Physicians' recommendations for mammography: do tailored messages make a difference?. Am J Public Health. 1994, 84: 43-49. 10.2105/AJPH.84.1.43.CrossRefPubMedPubMedCentral Skinner CS, Strecher VJ, Hospers H: Physicians' recommendations for mammography: do tailored messages make a difference?. Am J Public Health. 1994, 84: 43-49. 10.2105/AJPH.84.1.43.CrossRefPubMedPubMedCentral
25.
go back to reference Andresen EL, Wilson KA, Castillo A, Koopman C: Patient motivation for participating in clinical trials for depression: validation of the motivation for clinical trials inventory-depression. International Clinical Psychopharmacology. 2010, 25: 7-16. 10.1097/YIC.0b013e328332055c.CrossRefPubMed Andresen EL, Wilson KA, Castillo A, Koopman C: Patient motivation for participating in clinical trials for depression: validation of the motivation for clinical trials inventory-depression. International Clinical Psychopharmacology. 2010, 25: 7-16. 10.1097/YIC.0b013e328332055c.CrossRefPubMed
26.
go back to reference Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ: Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Archives of Internal Medicine. 2009, 169: 364-371. 10.1001/archinternmed.2008.564.CrossRefPubMedPubMedCentral Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ: Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Archives of Internal Medicine. 2009, 169: 364-371. 10.1001/archinternmed.2008.564.CrossRefPubMedPubMedCentral
27.
go back to reference DeFrank JT, Rimer BK, Gierisch JM, Bowling JM, Farrell D, Skinner CS: Impact of mailed and automated telephone reminders on receipt of repeat mammograms: a randomized controlled trial. American Journal of Preventive Medicine. 2009, 36: 459-467. 10.1016/j.amepre.2009.01.032.CrossRefPubMedPubMedCentral DeFrank JT, Rimer BK, Gierisch JM, Bowling JM, Farrell D, Skinner CS: Impact of mailed and automated telephone reminders on receipt of repeat mammograms: a randomized controlled trial. American Journal of Preventive Medicine. 2009, 36: 459-467. 10.1016/j.amepre.2009.01.032.CrossRefPubMedPubMedCentral
28.
go back to reference Gollwitzer PM, Sheeran P: Implementation Intentions and Goal Achievement: a meta-analysis of effects and processes. Advances in Experimental Social Psychology. 2006, 38: 69-119.CrossRef Gollwitzer PM, Sheeran P: Implementation Intentions and Goal Achievement: a meta-analysis of effects and processes. Advances in Experimental Social Psychology. 2006, 38: 69-119.CrossRef
29.
go back to reference Weinstein ND: Unrealistic optimism about susceptibility to health problems: conclusions from a community-wide sample. J Behav Med. 1987, 10: 481-500. 10.1007/BF00846146.CrossRefPubMed Weinstein ND: Unrealistic optimism about susceptibility to health problems: conclusions from a community-wide sample. J Behav Med. 1987, 10: 481-500. 10.1007/BF00846146.CrossRefPubMed
30.
go back to reference Khaw FM, Stobbart L, Murtagh MJ: 'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners. BMC Public Health. 2007, 7: 98-10.1186/1471-2458-7-98.CrossRefPubMedPubMedCentral Khaw FM, Stobbart L, Murtagh MJ: 'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners. BMC Public Health. 2007, 7: 98-10.1186/1471-2458-7-98.CrossRefPubMedPubMedCentral
31.
go back to reference Strauss SM, Munoz-Plaza C, Tiburcio NJ, Astone-Twerell J, Des Jarlais DC, Gwadz M, Hagan H, Osborne A, Rosenblum A: Barriers and facilitators to undergoing hepatitis C virus (HCV) testing through drug treatment programs. Journal of Drug Issues. 2008, 38: 1161-1185.CrossRef Strauss SM, Munoz-Plaza C, Tiburcio NJ, Astone-Twerell J, Des Jarlais DC, Gwadz M, Hagan H, Osborne A, Rosenblum A: Barriers and facilitators to undergoing hepatitis C virus (HCV) testing through drug treatment programs. Journal of Drug Issues. 2008, 38: 1161-1185.CrossRef
32.
go back to reference Aitken CK, Kerger M, Crofts N: Peer-delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users. Drug Alcohol Rev. 2002, 21: 33-37. 10.1080/09595230220119327.CrossRefPubMed Aitken CK, Kerger M, Crofts N: Peer-delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users. Drug Alcohol Rev. 2002, 21: 33-37. 10.1080/09595230220119327.CrossRefPubMed
Metadata
Title
Reasons for compliance or noncompliance with advice to test for hepatitis C via an internet-mediated blood screening service: a qualitative study
Authors
Freke R Zuure
Titia Heijman
Anouk T Urbanus
Maria Prins
Gerjo Kok
Udi Davidovich
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-293

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue